Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOLSTONE
2025-524191-38-00Phase 4Authorised
- Sponsor
- Spaarne Gasthuis
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of atorvastatin in cholelithiasis (2 arms), sponsored by Spaarne Gasthuis. Planned start Mar 2026; status: authorised.
02
Drugs
atorvastatin
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on 2025-524191-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524191-38-00.